NEW YORK CITY, NY / ACCESS Newswire / March 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Key Takeaways Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...

Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction ...

Raymond James Financial Inc. bought a new stake in Bausch + Lomb Co. (NYSE:BLCO – Free Report) during the fourth quarter, ...

Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, ...

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 ...

Bausch + Lomb has voluntarily recalled IOLs included on its enVista platform, including enVista Aspire, enVista Envy and ...

Bausch + Lomb has initiated a voluntary recall of its enVista platform intraocular lenses (IOLs) following reports of TASS.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall of intraocular lenses ...

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of some of its intraocular lenses due to safety concerns. On Thursday ...

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...